Short ‐term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo‐controlled, double blind, cross‐over pilot study
Diabetes, Obesity and Metabolism, EarlyView.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Andreas
Melmer
MD
,
Patrick
Kempf
MD
,
Lukas
Lunger
MD
,
Thomas R.
Pieber
MD
,
Julia K.
Mader
MD
,
Christoph
Stettler
MD
,
Herbert
Tilg
MD
,
Christoph F.
Ebenbichler
MD
,
Markus
Laimer
MD Source Type: research
More News: Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Eating Disorders & Weight Management | Endocrinology | Forxiga | Insulin | Obesity | Study